To seek capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.9% |
AstraZeneca | 5.3% |
Vodafone Group | 5.3% |
BAE Systems | 5.2% |
Royal Dutch Shell | 5.0% |
Babcock International | 4.8% |
Croda International | 4.5% |
British American Tobacco | 4.2% |
VT Group | 4.2% |
BP | 4.1% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.9% |
AstraZeneca | 5.3% |
Vodafone Group | 5.3% |
BAE Systems | 5.2% |
Other | 78.3% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/11/2001 |
---|---|
Fund Manager | Tim Steer |
TER | - |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | 100 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.12 |
You are here: research